Mobile Menu

Neuren Pharmaceuticals Limited - Australian Company Profile

Enterprise Type: Public Company

ASX Code: NEU

What does Neuren Pharmaceuticals Limited do?

Neuren Pharmaceuticals is a Public Company that generates the majority of its income from the Pharmaceutical Product Manufacturing industry.

In 2023 the company generated total revenue of $240,063,000 including sales and other revenue. The exact number of employees for this organisation is not available.

The Chief Executive of Neuren Pharmaceuticals is Mr Jon Pilcher whose official title is Chief Executive Officer/Managing Director. The Chairman of Neuren Pharmaceuticals is Mr Patrick Davies whose official title is Non-Executive Chair.

Neuren Pharmaceuticals Limited - Products & Brands

Neuren Pharmaceuticals Limited is a biopharmaceutical company that develops drugs for neurological disorders such as Trofinetide (NNZ-2566) for Rett syndrome and Fragile X syndrome, and NNZ-2591 for Phelan-McDermid syndrome, Angelman syndrome, Pitt Hopkins syndrome, and Prader-Willi syndrome.

Neuren Pharmaceuticals Limited - Key Personnel

To view Neuren Pharmaceuticals Limited's full key personnel, see purchase options.

Neuren Pharmaceuticals Limited - Financial Statements

Neuren Pharmaceuticals Limited Financial Profit & Loss Account

BALANCE DATE 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019
Sales Revenue 231,925.0 14,553.0 N/A 0.0 0.0
Other Revenue
Total Revenue
Cost of Goods Sold
Depreciation
R & D Expenditure
To view all financial data for Neuren Pharmaceuticals Limited, see purchase options.

Neuren Pharmaceuticals Limited's Competitive Environment

Neuren Pharmaceuticals Limited operates in the following industries:

Neuren Pharmaceuticals Limited's main competitors:

To view all of Neuren Pharmaceuticals Limited's operating industries and competitors, see purchase options.

Looking for IBISWorld Industry Reports?

Gain strategic insight and analysis on 700+ Australian industries
(& thousands of global industries)

Enterprise Profiles - table of contents

Enterprise Details

Get a high-level overview of Neuren Pharmaceuticals Limited, including registered business details, an enterprise synopsis, SWOT analysis and main brands and products.

Key Personnel

We outline the key personnel at Neuren Pharmaceuticals Limited by position type and title.

Enterprise Financials

Get a full view of Neuren Pharmaceuticals Limited’s financials, including Profit and Loss Account (Revenue, Interest, Profit and Loss, and Audit Fees) and Balance Sheet (Current Assets, Non-Current Assets, Current Liabilities, Non-Current Liabilities, Shareholders’ Equity), as well as Number of Employees, Number of Share on Issue, Market Capitalisation and Earnings per Share where available. Note: we do not provide a full financial details for all company profiles.

Growth & Ratios

Get a clearer picture of Neuren Pharmaceuticals Limited’s performance, with key financial ratios and data on financial growth.

Operating Segments

Understand the main operating divisions of Neuren Pharmaceuticals Limited, including Revenue and Assets under each Segment, Industries and Geographic Locations Neuren Pharmaceuticals Limited operates in.

Competitor Benchmarking

Compare Neuren Pharmaceuticals Limited’s financial ratios and growth to peers in their industries of operation for a clearer picture of performance.

Major Shareholders

We outline the ultimate parent and largest shareholders of Neuren Pharmaceuticals Limited.

Subsidiaries

View a list of Neuren Pharmaceuticals Limited’s associated companies, holding company, joint ventures and trusts, both domestic and international.

History

Find out more about the history and background of Neuren Pharmaceuticals Limited, including founding information, past announcements, mergers and major projects.

Why buy this enterprise profile on Neuren Pharmaceuticals Limited?

IBISWorld enterprise profiles enable you to:

  • Understand a enterprise’s competitive landscape
  • Identify industry trends a enterprise is exposed to
  • Inform your decisions for marketing, strategy and planning
  • Target key enterprise personnel

The profile on BHP Group Limited includes:

  • Enterprise History and Synopsis
  • Overview of Brands and Products
  • Enterprise Financial Statements and Financial Ratios
  • Key Enterprise Personnel
  • Subsidiaries, Shareholders and Ownership Structure
  • Service Providers

IBISWorld provides profiles on thousands of leading enterprises across Australia and New Zealand, as well as reports on thousands of industries around the world. Our clients rely on our information and data to stay up-to-date on business and industry trends. Our expert reports are thoroughly researched, reliable and current, enabling you to make faster, better business decisions.

Purchase to read full report

100% Money Back Guarantee Digicert Trusted
Download Sample Report

Included in Report

  • Enterprise History & Synopsis Enterprise History & Synopsis
  • Enterprise Financial Statements Enterprise Financial Statements
  • Financial Ratios Financial Ratios
  • Industry Averages Industry Averages
  • Competitive Landscape Competitive Landscape
  • Key Enterprise Personnel Key Enterprise Personnel
  • Subsidiaries & Ownership Structure Subsidiaries & Ownership Structure

View Top 2,000 Companies

Trusted by More Than 10,000 Clients Around the World

  • IBISWorld client - VISA
  • IBISWorld client - ADP
  • IBISWorld client - Deloitte
  • IBISWorld client - AMEX
  • IBISWorld client - Bank of Montreal